← All quick references

ClearRounds Health · Cardiology · Quick Reference

Cardiomyopathy Overview: Dilated, Hypertrophic, Restrictive

PDF coming soon
Heart Failure & CardiomyopathyIntermediateIn progressOne-page PDF

Compare DCM, HCM, and restrictive cardiomyopathy with causes, echo clues, workup, treatment, and referral triggers.

Combines dilated, hypertrophic, and restrictive cardiomyopathy on one comparison sheet.

Last reviewed

Pending initial clinical review

Sources / guidelines to verify

  • 2024 AHA/ACC HCM Guideline
  • 2022 AHA/ACC/HFSA Heart Failure Guideline
Disclaimer: Educational reference only. Not a substitute for clinician judgment, local protocols, or current guideline review.

One-page reference

Draft content pending the site owner’s clinical review. Verify against the sources above and local protocol before clinical use.

1

What it is / why it matters

  • Diseases of heart muscle. Three classic phenotypes: dilated (DCM), hypertrophic (HCM), and restrictive (RCM).
  • Phenotype guides workup, treatment, family screening, and sudden-death risk assessment.
2

Compare the three

FeatureDCMHCMRCM
Ejection fractionReducedUsually preservedPreserved / near-normal
HallmarkDilated LV, systolic dysfunctionAsymmetric septal hypertrophy, SAM, LVOT obstructionStiff ventricle, impaired filling, biatrial enlargement
Common causesIdiopathic, ischemic, genetic, alcohol, tachycardia-mediated, peripartum, myocarditisSarcomere gene mutations (autosomal dominant)Amyloid, sarcoid, hemochromatosis, radiation, fibrosis
Key risksHF, arrhythmia, SCDSCD (esp. young/athletes), AF, HFHF, AF, conduction disease
3

Diagnostic clues & workup

  • Echocardiography is first-line; cardiac MRI adds tissue characterization (fibrosis, infiltration).
  • HCM: murmur intensifies with Valsalva/standing (less preload); screen for LVOT obstruction.
  • RCM: look for infiltrative disease — suspect amyloid with LVH + low ECG voltage + neuropathy → PYP scan and serum/urine free light chains.
  • Genetic testing and first-degree relative screening for HCM and many DCM cases.
4

Management framework

DCM

  • Full HFrEF GDMT (see HFrEF reference); treat the underlying cause
  • ICD/CRT by EF and risk after GDMT optimization

HCM

  • Avoid dehydration and arterial vasodilators if obstructive
  • Beta-blocker or verapamil; disopyramide or a cardiac myosin inhibitor (e.g., mavacamten) for obstructive symptoms
  • SCD risk stratification for ICD; septal reduction (myectomy/alcohol ablation) for refractory obstruction; activity counseling

RCM

  • Treat the underlying disease (e.g., disease-specific amyloid therapy)
  • Cautious diuresis for congestion; manage AF and conduction disease
5

Red flags / escalate now

  • HCM with syncope, exertional symptoms, or a family history of sudden death → urgent risk stratification.
  • New high-grade conduction disease with HF → consider infiltrative disease (sarcoid/amyloid).
6

Clinic pearls

  • HCM is a leading cause of sudden cardiac death in young athletes.
  • A preserved EF does not mean a normal heart — HCM and RCM both cause symptoms with normal EF.
  • Suspect cardiac amyloidosis in "HFpEF" with LVH, low voltage, bilateral carpal tunnel, or neuropathy.
7

Sources to verify

  • 2024 AHA/ACC Hypertrophic Cardiomyopathy Guideline
  • 2022 AHA/ACC/HFSA Heart Failure Guideline
  • 2023 ACC ECDP on Cardiac Amyloidosis

Related quick references

Suggest an edit or request this reference

Spot something to improve, or want this one-pager prioritized? Send feedback to the ClearRounds Health team.

Share feedback →
ClearRounds Health · Cardiology — Cardiomyopathy Overview: Dilated, Hypertrophic, Restrictive Quick Reference · Last reviewed: Pending initial clinical review · Educational reference only. Not a substitute for clinician judgment, local protocols, or current guideline review.